Recursion Pharmaceuticals Summit Therapeutics: 2026 Insight
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Knowing where to keep your cash savings securely is essential for peace of mind. Explore the safest options available to you.
22,893 articlesTwo biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Strategy disclosed a record Bitcoin liquidation of $216 million over the past week, signaling a dramatic shift toward...
Amazon stock defies volatility with strong AWS momentum and AI commitments, fueling a growing conviction among trader...
Jim Cramer warned that semiconductor stocks could slide as margin selling weighs on the sector, pointing investors to...
Nebius is carving a niche in AI cloud services with data centers and ML software. This guide breaks down what buying ...
Warner Bros. Discovery’s latest quarterly results underscore a tougher operating environment even as deal drama swirl...
Gap reports eight straight quarters of positive comps and a multi-decade margin high, prompting a televised reaction ...
Bumble reports softer user growth and a hefty impairment bill, even as cash flow improves. The AI-driven reboot is dr...
Analysts push a higher target for NVIDIA as demand for Blackwell and Vera Rubin accelerates. The latest guidance sign...
IonQ is set to release Q1 2026 results after the bell, with investors weighing growth across five acquisitions, a Sky...
JPMorgan cuts McDonald’s price target to $305 amid softer same-store-sales, signaling a shift toward efficiency at ex...
Alibaba reports a pivotal Q4 2026, showing strong cloud and AI momentum while profits wobble. The move hints at a new...